Non-invasive skin sampling detects systemically administered drugs in humans

Clinical testing typically relies on invasive blood draws and biopsies. Alternative methods of sample collection are continually being developed to improve patient experience; swabbing the skin is one of the least invasive sampling methods possible. To show that skin swabs in combination with untarg...

Full description

Bibliographic Details
Main Authors: Morgan Panitchpakdi, Kelly C. Weldon, Alan K. Jarmusch, Emily C. Gentry, Arianna Choi, Yadira Sepulveda, Shaden Aguirre, Kunyang Sun, Jeremiah D. Momper, Pieter C. Dorrestein, Shirley M. Tsunoda
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321436/?tool=EBI
_version_ 1818017264761307136
author Morgan Panitchpakdi
Kelly C. Weldon
Alan K. Jarmusch
Emily C. Gentry
Arianna Choi
Yadira Sepulveda
Shaden Aguirre
Kunyang Sun
Jeremiah D. Momper
Pieter C. Dorrestein
Shirley M. Tsunoda
author_facet Morgan Panitchpakdi
Kelly C. Weldon
Alan K. Jarmusch
Emily C. Gentry
Arianna Choi
Yadira Sepulveda
Shaden Aguirre
Kunyang Sun
Jeremiah D. Momper
Pieter C. Dorrestein
Shirley M. Tsunoda
author_sort Morgan Panitchpakdi
collection DOAJ
description Clinical testing typically relies on invasive blood draws and biopsies. Alternative methods of sample collection are continually being developed to improve patient experience; swabbing the skin is one of the least invasive sampling methods possible. To show that skin swabs in combination with untargeted mass spectrometry (metabolomics) can be used for non-invasive monitoring of an oral drug, we report the kinetics and metabolism of diphenhydramine in healthy volunteers (n = 10) over the course of 24 hours in blood and three regions of the skin. Diphenhydramine and its metabolites were observed on the skin after peak plasma levels, varying by compound and skin location, and is an illustrative example of how systemically administered molecules can be detected on the skin surface. The observation of diphenhydramine directly from the skin supports the hypothesis that both parent drug and metabolites can be qualitatively measured from a simple non-invasive swab of the skin surface. The mechanism of the drug and metabolites pathway to the skin’s surface remains unknown.
first_indexed 2024-04-14T07:23:54Z
format Article
id doaj.art-d127b390ce8e45eb868dec29462c4c88
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-14T07:23:54Z
publishDate 2022-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-d127b390ce8e45eb868dec29462c4c882022-12-22T02:06:04ZengPublic Library of Science (PLoS)PLoS ONE1932-62032022-01-01177Non-invasive skin sampling detects systemically administered drugs in humansMorgan PanitchpakdiKelly C. WeldonAlan K. JarmuschEmily C. GentryArianna ChoiYadira SepulvedaShaden AguirreKunyang SunJeremiah D. MomperPieter C. DorresteinShirley M. TsunodaClinical testing typically relies on invasive blood draws and biopsies. Alternative methods of sample collection are continually being developed to improve patient experience; swabbing the skin is one of the least invasive sampling methods possible. To show that skin swabs in combination with untargeted mass spectrometry (metabolomics) can be used for non-invasive monitoring of an oral drug, we report the kinetics and metabolism of diphenhydramine in healthy volunteers (n = 10) over the course of 24 hours in blood and three regions of the skin. Diphenhydramine and its metabolites were observed on the skin after peak plasma levels, varying by compound and skin location, and is an illustrative example of how systemically administered molecules can be detected on the skin surface. The observation of diphenhydramine directly from the skin supports the hypothesis that both parent drug and metabolites can be qualitatively measured from a simple non-invasive swab of the skin surface. The mechanism of the drug and metabolites pathway to the skin’s surface remains unknown.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321436/?tool=EBI
spellingShingle Morgan Panitchpakdi
Kelly C. Weldon
Alan K. Jarmusch
Emily C. Gentry
Arianna Choi
Yadira Sepulveda
Shaden Aguirre
Kunyang Sun
Jeremiah D. Momper
Pieter C. Dorrestein
Shirley M. Tsunoda
Non-invasive skin sampling detects systemically administered drugs in humans
PLoS ONE
title Non-invasive skin sampling detects systemically administered drugs in humans
title_full Non-invasive skin sampling detects systemically administered drugs in humans
title_fullStr Non-invasive skin sampling detects systemically administered drugs in humans
title_full_unstemmed Non-invasive skin sampling detects systemically administered drugs in humans
title_short Non-invasive skin sampling detects systemically administered drugs in humans
title_sort non invasive skin sampling detects systemically administered drugs in humans
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321436/?tool=EBI
work_keys_str_mv AT morganpanitchpakdi noninvasiveskinsamplingdetectssystemicallyadministereddrugsinhumans
AT kellycweldon noninvasiveskinsamplingdetectssystemicallyadministereddrugsinhumans
AT alankjarmusch noninvasiveskinsamplingdetectssystemicallyadministereddrugsinhumans
AT emilycgentry noninvasiveskinsamplingdetectssystemicallyadministereddrugsinhumans
AT ariannachoi noninvasiveskinsamplingdetectssystemicallyadministereddrugsinhumans
AT yadirasepulveda noninvasiveskinsamplingdetectssystemicallyadministereddrugsinhumans
AT shadenaguirre noninvasiveskinsamplingdetectssystemicallyadministereddrugsinhumans
AT kunyangsun noninvasiveskinsamplingdetectssystemicallyadministereddrugsinhumans
AT jeremiahdmomper noninvasiveskinsamplingdetectssystemicallyadministereddrugsinhumans
AT pietercdorrestein noninvasiveskinsamplingdetectssystemicallyadministereddrugsinhumans
AT shirleymtsunoda noninvasiveskinsamplingdetectssystemicallyadministereddrugsinhumans